Skip to main content

Leadership Team

Our Leadership Team is comprised of dedicated cell and gene therapy experts with the GMP manufacturing know-how and regulatory understanding to drive your product from clinical trial to commercial supply for the global market.

Bev Menner
Chief Executive Officer

Bev has over 20 years’ experience across the Australian and global biopharmaceutical & healthcare sectors. She holds a PhD in molecular medicine with additional qualifications in genetic counselling, project management and decision analysis. Bev commenced her career with Postdoctoral roles in cancer research at Memorial Sloan Kettering Cancer Centre and the Peter MacCallum Cancer Centre, before moving to genetic counselling practice and then commercial roles in research & development, portfolio management and strategic partnerships in the pharmaceutical industry.  

A/Prof Dominic Wall
Chief Scientific Officer

Dominic carries final product accountability under our licences, including those with the Therapeutic Goods Administration (TGA). As a co-founder of Cell Therapies, Dominic is an expert in CAR-T cell process development and analytics. He also has an appointment at the Peter MacCallum Cancer Centre, as Executive Director-Business Ventures, oversighting its Centres of Excellence in Cellular Immunotherapy, Theranostics, and Pathology.

Kate MacCormack
Director of Human Resources 

Kate has 20 years of experience working in People and Culture roles across health, finance and professional services. She is passionate about supporting people to be their best at work and executes this through building strong relationships, understanding and alternative perspectives. 


Bindhu Radhakrishnan
Director Of Quality
Bindhu leads our QA, QC and Validation teams, with overall responsibility for the QMS and GMP compliance at Cell Therapies. She has over 20 years of experience in the pharma industry and is a passionate supporter of embedding Quality and Continuous improvement. 


Nathan Smith
Director of Business Development 
Nathan oversees all business development activities at Cell Therapies, including new client projects and contracts; industry, government, and academic collaborations; and marketing and external communications. He has over 20 years of experience within the cell therapy and biotech industries, with a strong background in GMP clinical and commercial manufacturing operations.


Heidi Bergman
Director of Production
Heidi leads the production and portfolio activities at Cell Therapies with the goal of delivering cutting-edge therapies to improve patient outcomes. Heidi has over 20 years’ experience across the Australian and global biopharmaceutical industry in both clinical and commercial manufacturing. She holds in-depth expertise in quality by design methodologies, and end-to-end GMP production processes.


James Lockyer
Chief Financial Officer
James is an ACCA Fellow and Chartered Accountant with over 20 years of experience. James has held senior financial leadership roles with particular focus on strategic, commercial and data analytics development in healthcare, creative industries, facilities management and environmental services. He has led change and transformation programs, developed teams to realise their potential and champions the role of Finance as an enabler and value-creator.

Behind the Scenes

Our team of experts spans the medical, healthcare, and scientific communities, driving the development and commercialization of groundbreaking cell and gene therapies.

Our Board

Extensive experience across the Australian healthcare and medical sector, and biotechnology industry.

Meet Our Board

Scientific Advisors

Expertise and knowledge from across the cell and gene therapy, health, and medical sectors

Meet our Advisors